Both in Pharmaceuticals
ADC Therapeutics SA vs Evommune
Over the past year ADCT returned −65.4% and EVMN returned −74.8%; their daily moves had a correlation of 0.05.
ADCT −65.4% EVMN −74.8%Growth of $1, one year, split-adjusted
| Metric | ADCT | EVMN |
|---|---|---|
| Price | $1.44 | $5.10 |
| Market cap | $183.8M | $185.1M |
| Today | −10.00% | −2.11% |
| 1 month | +11.6% | −42.0% |
| 6 months | −63.5% | −79.9% |
| Year to date | −59.2% | −70.2% |
| 1 year | −64.6% | — |
| Revenue growth (YoY) | +2.2% | — |
| Gross margin | 87.8% | — |
| Net margin | −86.1% | — |
| P/E (TTM) | — | — |
| Price / sales | 2.3× | — |
| Net cash | $102.5M | $200.4M |
| Dividend yield | — | — |
| Volatility (60d) | 99.4% | 77.4% |
| Short % of float | 6.9% | 13.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).